Previous 10 | Next 10 |
The following slide deck was published by Synlogic, Inc. in conjunction with this Read more ...
Synlogic (Nasdaq:SYBX) announced today that Caroline Kurtz, Ph.D., Synlogic’s Head of Metabolism, will provide a corporate update at Oppenheimer’s 29th Annual Healthcare Conference at 3:20 pm ET on Wednesday, March 20, 2019, in New York City. A live webcast of the prese...
Synlogic, Inc. (SYBX) Q4 2016 Results Earnings Conference Call March 12, 2019, 08:00 AM ET Company Participants Elizabeth Wolffe - Head, Investor Relations and Corporate Communications Aoife Brennan - President, Chief Executive Officer and Chief Medical Officer Todd Shegog - Chie...
Synlogic (NASDAQ: SYBX ): Q4 GAAP EPS of -$0.47 beats by $0.07 . More news on: Synlogic, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
– Ended 2018 with approximately $123 million in cash and investments, which provides runway through 2020 – – Clinical trial readouts expected in mid-2019 from two Synthetic Biotic ™ medicines and first IND application expected from Synlogic’s immuno-...
Synlogic, Inc ., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced the advancement of Synthetic Biotic medicines to the lead optimization stage in its collaboration with AbbVie , a global ...
Synlogic, Inc. ( Nasdaq: SYBX ), a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, announced today that the Company will release its fourth quarter and full year 2018 financial results before the market opens on Tuesday, March 12, 2019. T...
Synlogic (Nasdaq:SYBX) announced today that Aoife Brennan, M.B., B.Ch., Synlogic’s president and chief executive officer, will present at the following upcoming investor conferences: Chardan’s 1 st Annual Microbiome Medicines Summit at 2:05pm ET on Thursday, March 7,...
Synlogic (Nasdaq:SYBX) announced today that Aoife Brennan, M.B., B.Ch., Synlogic’s president and chief executive officer, will provide a corporate update at the SVB Leerink 8th Annual Global Healthcare Conference at 1:30 pm ET on Thursday, February 28, 2019, in New York City. ...
Quick Take Kaleido Biosciences ( OTC:KLDO ) intends to raise $100 million from the sale of its common stock, per an amended registration statement . The company is developing microbiome-centric treatment candidates for hyperammonemia and other urea cycle disorders. KLDO is seeking a hig...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the first quarter 2024 and provided a corporate update. In March 2024, t...
CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the fourth quarter and full year ending December 31, 2023. The Company...